Invesco Mutual FundEquity Schemes - Mid Cap Fund13.7 years
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
20 Feb 2020 – 6 Nov 2020
Trough 23 Mar 2020 · recovered in 228 days
-34.1%
7 Jan 2013 – 9 Dec 2013
Trough 28 Aug 2013 · recovered in 103 days
-21.9%
16 Dec 2024 – 6 Jun 2025
Trough 28 Feb 2025 · recovered in 98 days
-20.1%
17 Jan 2022 – 1 Dec 2022
Trough 20 Jun 2022 · recovered in 164 days
-20.1%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
89
Vs category
44
Consistency
49
Risk-adjusted
73
Drawdown
15
Mean
54
31 Aug 2026 · 42 holdings · top 10 are 48.9%.
Prestige Estates Projects Ltd
Real Estate
7.3%
Max Healthcare Institute Ltd
Healthcare
6.5%
The Federal Bank Ltd
Financial
6.0%
Meesho Ltd.
Consumer Discretionary
4.8%
Manipal Health Enterprises Ltd
Healthcare
4.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
10 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
8 Sept 2026
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 11 Sept 2026
Engine status
Monitor
Recent evidence
Why this status
No status reasons yet. History is still thin.
Supporting reads
Same-category peers with enough history to inspect beside this fund.
Helios Mutual Fund
Caveat: Lower trailing returns
HSBC Mutual Fund
Caveat: Higher volatility
WhiteOak Capital Mutual Fund
Caveat: Lower trailing returns
Kotak Mahindra Mutual Fund
Caveat: Deeper drawdown · Lower trailing returns
Mahindra Manulife Mutual Fund
Caveat: Higher volatility · Lower trailing returns
Invesco Mutual FundEquity Schemes - Mid Cap Fund13.7 years
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
NAV
15 Sept 2026 · +7.4% over 1Y
235.37
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
15 Sept 2026
-4.5%
20 Feb 2020 – 6 Nov 2020
Trough 23 Mar 2020 · recovered in 228 days
-34.1%
7 Jan 2013 – 9 Dec 2013
Trough 28 Aug 2013 · recovered in 103 days
-21.9%
16 Dec 2024 – 6 Jun 2025
Trough 28 Feb 2025 · recovered in 98 days
-20.1%
17 Jan 2022 – 1 Dec 2022
Trough 20 Jun 2022 · recovered in 164 days
-20.1%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
89
Vs category
44
Consistency
49
Risk-adjusted
73
Drawdown
15
Mean
54
31 Aug 2026 · 42 holdings · top 10 are 48.9%.
Prestige Estates Projects Ltd
Real Estate
7.3%
Max Healthcare Institute Ltd
Healthcare
6.5%
The Federal Bank Ltd
Financial
6.0%
Meesho Ltd.
Consumer Discretionary
4.8%
Manipal Health Enterprises Ltd
Healthcare
4.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
10 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
8 Sept 2026
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 11 Sept 2026
Engine status
Monitor
Recent evidence
Why this status
No status reasons yet. History is still thin.
Supporting reads